CA2589421C - Anticorps de la proteine erbb3 - Google Patents

Anticorps de la proteine erbb3 Download PDF

Info

Publication number
CA2589421C
CA2589421C CA2589421A CA2589421A CA2589421C CA 2589421 C CA2589421 C CA 2589421C CA 2589421 A CA2589421 A CA 2589421A CA 2589421 A CA2589421 A CA 2589421A CA 2589421 C CA2589421 C CA 2589421C
Authority
CA
Canada
Prior art keywords
antibody
erbb3
antibodies
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2589421A
Other languages
English (en)
Other versions
CA2589421A1 (fr
Inventor
Robert Akita
Mark Sliwkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from CA002246429A external-priority patent/CA2246429C/fr
Publication of CA2589421A1 publication Critical patent/CA2589421A1/fr
Application granted granted Critical
Publication of CA2589421C publication Critical patent/CA2589421C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2589421A 1996-03-27 1997-03-07 Anticorps de la proteine erbb3 Expired - Lifetime CA2589421C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62403696A 1996-03-27 1996-03-27
US08/624,036 1996-03-27
CA002246429A CA2246429C (fr) 1996-03-27 1997-03-07 Anticorps de la proteine erbb3

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002246429A Division CA2246429C (fr) 1996-03-27 1997-03-07 Anticorps de la proteine erbb3

Publications (2)

Publication Number Publication Date
CA2589421A1 CA2589421A1 (fr) 1997-10-02
CA2589421C true CA2589421C (fr) 2012-12-18

Family

ID=38326392

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2589421A Expired - Lifetime CA2589421C (fr) 1996-03-27 1997-03-07 Anticorps de la proteine erbb3

Country Status (1)

Country Link
CA (1) CA2589421C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白

Also Published As

Publication number Publication date
CA2589421A1 (fr) 1997-10-02

Similar Documents

Publication Publication Date Title
AU727082B2 (en) ErbB3 antibodies
US5968511A (en) ErbB3 antibodies
CA2269204C (fr) Anticorps anti-erbb2
US7371376B1 (en) Anti-ErbB2 antibodies
CA2589421C (fr) Anticorps de la proteine erbb3
HK1097857A (en) Erbb3 antibodies
MXPA98007723A (en) Erbb3 antibodies
AU4392901A (en) Anti-ErB2 antibodies
AU2478901A (en) anti-ErbB2 antibodies

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170307